Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
dal-GenE trial of dalcetrapib after recent acute coronary syndrome in ADCY9 rs1967309 AA genotype patients
2015-003895-65Phase 3Completed
- Sponsor
- DalCor Pharmaceuticals
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute coronary syndrome (ACS) comparing Dalcetrapib with Placebo (2 arms). Started Mar 2016; status: completed.
02
Drugs
dalcetrapib
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on 2015-003895-65.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003895-65.